Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 83
This article has been cited by
Huilin Tang,Tamara Hunter,Yongfang Hu,Suo-Di Zhai,Xiaoyan Sheng,Roger J Hart,Huilin Tang
David A. Grainger,Bruce L. Tjaden,Laura L. Tatpati
3Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis
Miriam Baumgarten,Lukasz Polanski,Bruce Campbell,Nick Raine-Fenning
Human Fertility.2013;16(3)168
4Dopamine agonists for preventing ovarian hyperstimulation syndrome
Huilin Tang,Selma Mourad,Suo-Di Zhai,Roger J Hart
Cochrane Database of Systematic Reviews.2016;16(3)168
5Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists
Hortensia Ferrero,Carmen M. García-Pascual,Raúl Gómez,Francisco Delgado-Rosas,Omar Cauli,Carlos Simón,Francisco Gaytán,Antonio Pellicer
Fertility and Sterility.2014;101(5)1411
6Etiology of OHSS and use of dopamine agonists
Sérgio Reis Soares
Fertility and Sterility.2012;97(3)517
7VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status
Nikita Naredi,Pankaj Talwar,K. Sandeep
Medical Journal Armed Forces India.2014;70(1)58
8Dopamine agonists in prevention of ovarian hyperstimulation syndrome
Miro Kasum,Hrvoje Vrcic,Patrik Stanic,Davor Ježek,Slavko Oreškovic,Lidija Beketic-Oreškovic,Marijeta Pekez
Gynecological Endocrinology.2014;30(12)845
9Subchronic Oral Bromocriptine Methanesulfonate Enhances Open Field Novelty-Induced Behavior and Spatial Memory in Male Swiss Albino Mice
Olakunle James Onaolapo,Adejoke Yetunde Onaolapo
Neuroscience Journal.2013;2013(12)1
10An update on the prevention of ovarian hyperstimulation syndrome
Omar El Tokhy,Julia Kopeika,Tarek El-Toukhy
Women's Health.2016;12(5)496
11Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists
Hortensia Ferrero,Carmen M. García-Pascual,María Gaytán,Concepción Morales,Carlos Simón,Francisco Gaytán,Antonio Pellicer,Raúl Gómez
Fertility and Sterility.2014;102(5)1468
12Consensus statement on prevention and detection of ovarian hyperstimulation syndrome
Clare Boothroyd,Sonal Karia,Natasha Andreadis,Luk Rombauts,Neil Johnson,Michael Chapman
Australian and New Zealand Journal of Obstetrics and Gynaecology.2015;55(6)523
About us 
Editorial board 
Search articles 
Contact us 
Advertise With Us
My Preferences 

Submit articles online
Email alerts
Join our team of reviewers
Most polular articles
Recommend this journal